US 8822700
Hepatitis C virus inhibitors
granted A61KA61K31/4178A61K31/427
Quick answer
US patent 8822700 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/4178, A61K31/427, A61K31/444, A61K31/4545